샘플 요청 목록

 카트 문의
시장보고서
상품코드
1787176

세계의 원숭이두창 검사 시장

Monkeypox Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 279 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 원숭이두창 검사 시장은 2030년까지 1억 4,800만 달러에 이를 전망

2024년에 1억 2,220만 달러로 추정되는 원숭이두창 검사 세계 시장은 2024-2030년간 CAGR 3.2%로 성장하여 2030년에는 1억 4,800만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 중합효소 연쇄반응 기술은 CAGR 4.2%를 나타내고, 분석 기간 종료까지 8,330만 달러에 이를 것으로 예측됩니다. 측면 흐름 분석 기술 분야의 성장률은 분석 기간중 CAGR 2.0%로 추정됩니다.

미국 시장은 3,330만 달러로 추정, 중국은 CAGR6.3%로 성장 예측

미국의 원숭이두창 검사 시장은 2024년에 3,330만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 2,960만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.3%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.2%와 2.5%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.8%를 나타낼 전망입니다.

세계 원숭이두창 검사 시장 - 주요 동향 및 촉진요인 요약

최근 몇 년 동안 원숭이두창 검사 수요가 급증한 이유는 무엇일까?

세계적으로 유행하는 원숭이두창로 인해 바이러스 확산을 막기 위한 신속하고 신뢰할 수 있는 진단 검사의 필요성이 강조되고 있습니다. 원숭이두창는 원숭이두창 바이러스에 의해 발생하는 바이러스성 인수공통전염병으로 발열, 피부병변, 림프절 부종 등 천연두와 유사한 증상을 보입니다. 전 세계적으로 감염자가 증가함에 따라 각국 정부와 의료 기관은 감염을 조기에 발견하고 격리 조치를 시행하기 위해 검사를 강화하고 있습니다. 특히 도시나 인구밀도가 높은 지역에서는 바이러스의 전염성이 높아 진단 검사에 대한 수요가 증가하고 있습니다. 또한, 무증상 및 경증 환자가 출현함에 따라 눈에 보이는 증상 없이도 감염을 정확하게 감지할 수 있는 고감도 분자 검사의 필요성이 부각되고 있습니다. 전 세계 여행의 확대와 경제의 상호 연결은 원숭이두창의 확산을 더욱 가속화하고 광범위한 검사의 긴급한 필요성을 촉구하고 있습니다.

어떤 기술 혁신이 원숭이두창 검사 능력을 향상시키고 있는가?

첨단 진단 기술의 개발은 원숭이두창 검사의 정확성과 속도 향상에 중요한 역할을 하고 있습니다. 실시간 중합효소 연쇄반응(RT-PCR)과 같은 분자 기반 방법은 높은 민감도와 특이성으로 인해 원숭이두창를 검출하는 데 있어 표준이 되고 있습니다. 신속 항원 검사 또한 고위험군 대상의 신속한 선별검사를 위한 현장 진료 솔루션을 제공하기 위해 개발되고 있습니다. 또한, 차세대 염기서열 분석(NGS)은 바이러스의 변이를 추적하고 전파 패턴을 이해하기 위해 활용되고 있습니다. 진단 도구에 인공지능(AI)을 접목하여 검사 결과 해석의 효율성을 더욱 향상시키고, 의료 전문가의 업무 부담을 경감시키고 있습니다. 가정용 검사 키트도 접근성을 개선하고 취약한 지역사회의 자가 모니터링을 장려하기 위해 검토되고 있습니다.

정부의 규제와 공중보건에 대한 노력은 시장에 어떤 영향을 미치고 있는가?

세계 각국 정부와 보건 기관은 원숭이두창 발생을 억제하기 위해 광범위한 검사 전략을 시행하고 있으며, 이는 진단 솔루션에 대한 수요를 촉진하고 있습니다. 세계보건기구(WHO), 질병통제예방센터(CDC), 기타 세계 보건기관들은 검사 프로토콜에 대한 가이드라인을 발표하고 검사 시설 인프라에 대한 투자 확대를 추진하고 있습니다. 각국 정부는 또한 새로운 검사 키트의 규제 당국 승인을 신속히 진행하여 의료 환경으로의 배포를 가속화하기 위해 노력하고 있습니다. 조기 발견과 자가 격리를 강조하는 공중보건 캠페인은 저렴하고 광범위하게 이용할 수 있는 검사 옵션에 대한 수요 증가에 기여하고 있습니다. 이동식 검사 장치와 지역 기반 검진 프로그램의 확대는 시장 성장을 더욱 촉진하고 있습니다.

원숭이두창 검사 시장의 성장을 가속하는 주요 요인은?

원숭이두창 검사 시장의 성장은 전 세계 발병 증가, 진단 기술 발전, 정부의 검사 이니셔티브 등 여러 요인에 의해 주도되고 있습니다. 주요 요인 중 하나는 감염병 감시를 위한 투자 증가이며, 이는 진단 실험실과 신속 검사 인프라의 확대로 이어지고 있습니다. PCR 기반 검사의 채택이 증가하고, 휴대가 간편하고 신속한 항원 검사가 개발된 것도 시장 확대에 박차를 가하고 있습니다. 또한, 원숭이두창와 그 잠재적인 장기적 건강 영향에 대한 인식이 높아지면서 특히 고위험군 집단에서 검사 보급이 확대되고 있습니다. 혈청학적 검사 및 가정용 검사 솔루션에 대한 연구가 진행되고 있어 시장에 새로운 기회가 창출될 것으로 기대됩니다. 의료 시스템이 조기 발견과 봉쇄를 최우선 과제로 삼고 있기 때문에 향후 몇 년 동안 원숭이두창 검사 시장은 크게 성장할 것으로 예측됩니다.

부문

기술(중합효소 연쇄반응 기술, 측면 흐름 분석 기술, 기타 기술), 최종사용자(진단실험실, 병원 및 진료소, 기타 최종사용자)

조사 대상 기업 예

  • Aegis Sciences Corporation
  • Applied DNA Clinical Labs, LLC
  • ARUP Laboratories
  • BayCare Laboratories, LLC
  • Baylor Scott & White Advanced Diagnostics Laboratory
  • BioReference Health, LLC
  • CDR Laboratories, Inc
  • Cepheid
  • Curative Labs
  • DevLab Bio
  • Fulgent Genetics
  • Houston Methodist Hospital Pathology
  • Integrity Laboratories, LLC
  • Ipsum Diagnostics LLC
  • Johns Hopkins Medical Microbiology Laboratory
  • Labcorp
  • Mayo Clinic Laboratories
  • Quest Diagnostics
  • Sonic Healthcare

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.18

Global Monkeypox Testing Market to Reach US$148.0 Million by 2030

The global market for Monkeypox Testing estimated at US$122.2 Million in the year 2024, is expected to reach US$148.0 Million by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Polymerase Chain Reaction Technology, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$83.3 Million by the end of the analysis period. Growth in the Lateral Flow Assay Technology segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$33.3 Million While China is Forecast to Grow at 6.3% CAGR

The Monkeypox Testing market in the U.S. is estimated at US$33.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$29.6 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Monkeypox Testing Market - Key Trends & Drivers Summarized

Why Has the Demand for Monkeypox Testing Surged in Recent Years?

The global outbreak of monkeypox has underscored the critical need for rapid and reliable diagnostic testing to contain the spread of the virus. Monkeypox, a viral zoonotic disease caused by the monkeypox virus, presents symptoms similar to smallpox, including fever, skin lesions, and swollen lymph nodes. With cases rising worldwide, governments and healthcare institutions have ramped up testing efforts to identify infections early and implement isolation measures. The demand for diagnostic testing has increased due to the highly transmissible nature of the virus, especially in urban and high-density population areas. Additionally, the emergence of asymptomatic and mild cases has highlighted the necessity for sensitive molecular tests that can accurately detect infections even in the absence of visible symptoms. The expansion of global travel and interconnected economies has further accelerated the spread of monkeypox, driving the urgent need for widespread testing.

What Technological Innovations Are Enhancing Monkeypox Testing Capabilities?

The development of advanced diagnostic techniques has played a crucial role in improving the accuracy and speed of monkeypox testing. Molecular-based methods such as real-time polymerase chain reaction (RT-PCR) have become the gold standard for detecting monkeypox due to their high sensitivity and specificity. Rapid antigen tests are also being developed to provide point-of-care solutions for quick screening in high-risk populations. Additionally, next-generation sequencing (NGS) is being utilized to track viral mutations and understand transmission patterns. The integration of artificial intelligence (AI) in diagnostic tools has further improved the efficiency of test result interpretation, reducing the workload on healthcare professionals. At-home testing kits are also being explored to increase accessibility and encourage self-monitoring in vulnerable communities.

How Are Government Regulations and Public Health Initiatives Influencing the Market?

Governments and health organizations worldwide have implemented extensive testing strategies to control monkeypox outbreaks, fueling demand for diagnostic solutions. The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other global health agencies have issued guidelines on testing protocols, pushing for increased investment in laboratory infrastructure. Governments have also fast-tracked regulatory approvals for novel testing kits to accelerate deployment in healthcare settings. Public health campaigns emphasizing early detection and self-isolation have contributed to the rising demand for affordable and widely available testing options. The expansion of mobile testing units and community-based screening programs has further bolstered market growth.

What Are the Key Factors Driving Growth in the Monkeypox Testing Market?

The growth in the monkeypox testing market is driven by several factors, including increased global outbreaks, advancements in diagnostic technologies, and government-backed testing initiatives. One of the primary drivers is the rising investment in infectious disease surveillance, which has led to the expansion of diagnostic laboratories and rapid testing infrastructure. The increased adoption of PCR-based testing, coupled with the development of portable and rapid antigen tests, is further fueling market expansion. Additionally, growing awareness about monkeypox and its potential long-term health impacts has encouraged widespread testing, particularly in high-risk populations. The ongoing research into serological and at-home testing solutions is expected to create new opportunities in the market. As healthcare systems continue to prioritize early detection and containment, the monkeypox testing market is poised for significant growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Monkeypox Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Polymerase Chain Reaction Technology, Lateral Flow Assay Technology, Other Technologies); End-Use (Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Aegis Sciences Corporation
  • Applied DNA Clinical Labs, LLC
  • ARUP Laboratories
  • BayCare Laboratories, LLC
  • Baylor Scott & White Advanced Diagnostics Laboratory
  • BioReference Health, LLC
  • CDR Laboratories, Inc
  • Cepheid
  • Curative Labs
  • DevLab Bio
  • Fulgent Genetics
  • Houston Methodist Hospital Pathology
  • Integrity Laboratories, LLC
  • Ipsum Diagnostics LLC
  • Johns Hopkins Medical Microbiology Laboratory
  • Labcorp
  • Mayo Clinic Laboratories
  • Quest Diagnostics
  • Sonic Healthcare

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Monkeypox Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Incidences of Monkeypox Drive Accelerated Demand for Diagnostic Testing Solutions
    • Rising Awareness of Monkeypox Among Healthcare Providers Expands Addressable Market for Testing Solutions
    • Advancements in Molecular Diagnostic Technologies Propel Growth in Monkeypox Testing Accuracy and Speed
    • Strengthening Public Health Surveillance and Monitoring Initiatives Boost Demand for Monkeypox Testing Kits
    • Emergence of Monkeypox as a Public Health Concern Spurs Increased Government and Institutional Funding for Testing
    • Regulatory Approvals and Certification of New Diagnostic Tests Drive Market Confidence and Adoption
    • Expansion of Point-of-care Testing Solutions Enhances Accessibility and Speeds Monkeypox Diagnosis in Remote Areas
    • Increasing Focus on Global Preparedness for Emerging Infectious Diseases Strengthens Business Case for Monkeypox Testing
    • Surge in International Travel and Cross-border Movement Spurs Demand for Rapid Monkeypox Screening
    • Growing Need for Early Detection and Prevention of Monkeypox Increases Market Demand for Reliable Testing Platforms
    • Technological Advancements in PCR and Lateral Flow Assays Enhance Market Adoption for Monkeypox Testing Kits
    • Integration of Artificial Intelligence and Automation in Monkeypox Testing Improves Efficiency and Diagnostic Precision
    • Expanding Focus on Genomic Surveillance and Tracking of Monkeypox Strains Drives Demand for High-Throughput Testing
    • Increasing Healthcare Budgets and Investment in Diagnostic Infrastructure Strengthen the Market for Monkeypox Testing
    • Expansion of Telemedicine and Remote Healthcare Services Increases Adoption of At-home and Digital Monkeypox Testing Solutions
    • Rising Incidents of Monkeypox Outbreaks in High-Risk Populations Creates Urgency for Enhanced Testing Solutions
    • Public Health Initiatives and Education on Monkeypox Transmission Boost Demand for Testing Kits in Vulnerable Regions
    • Demand for Multiplex Testing Platforms that Can Simultaneously Detect Monkeypox and Other Viruses Expands Market Opportunity
    • Growing Collaboration Between Governments, NGOs, and the Private Sector Accelerates Market Expansion for Monkeypox Testing Solutions
    • Emerging Market Access and Distribution Channels for Monkeypox Testing Kits Strengthen Global Availability and Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Monkeypox Testing Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Monkeypox Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polymerase Chain Reaction Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Polymerase Chain Reaction Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lateral Flow Assay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lateral Flow Assay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Lateral Flow Assay Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Monkeypox Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Monkeypox Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Monkeypox Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Monkeypox Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Monkeypox Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Monkeypox Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Monkeypox Testing by Technology - Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Monkeypox Testing by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Lateral Flow Assay Technology and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Monkeypox Testing by End-Use - Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Monkeypox Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제